A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis

Clinical trial NCT07027163 · COMPLETED

Trial details

NCT number: NCT07027163
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Food Hypersensitivity Anaphylaxis

Start date: 2023-06-01
Primary completion: 2023-09-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.